BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5346043)

  • 21. Isolation and identification of 3-propylidene-delta 1-pyrroline-5-carboxylic acid, a biosynthetic precursor of lincomycin.
    Kuo MS; Yurek DA; Coats JH; Chung ST; Li GP
    J Antibiot (Tokyo); 1992 Nov; 45(11):1773-7. PubMed ID: 1468986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chrolactomycin, a novel antitumor antibiotic produced by Streptomyces sp.
    Nakai R; Kakita S; Asai A; Chiba S; Akinaga S; Mizukami T; Yamashita Y
    J Antibiot (Tokyo); 2001 Oct; 54(10):836-9. PubMed ID: 11776440
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lincomycin formation by strain R-367 on a complex medium not containing corn steep].
    Kochetkova GV; Nechaeva NP; Ukholina RS
    Antibiotiki; 1976 Feb; 21(2):99-102. PubMed ID: 945038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on mycotrienin antibiotics, a novel class of ansamycins. II. Structure elucidation and biosynthesis of mycotrienins I and II.
    Sugita M; Sasaki T; Furihata K; Seto H; Otake N
    J Antibiot (Tokyo); 1982 Nov; 35(11):1467-73. PubMed ID: 7161185
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotics produced by mutants of Streptomyces caelestis. II. N-demethylcelesticetin and N-demethyl-7-O-demethylcelesticetin.
    Argoudelis AD; Coats JH; Lemaux PG; Sebek OK
    J Antibiot (Tokyo); 1973 Jan; 26(1):7-14. PubMed ID: 4781281
    [No Abstract]   [Full Text] [Related]  

  • 26. RS-22A, B and C: new macrolide antibiotics from Streptomyces violaceusniger. II. Physico-chemical properties and structure elucidation.
    Ubukata M; Morita T; Osada H
    J Antibiot (Tokyo); 1995 Apr; 48(4):293-9. PubMed ID: 7775265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on pentenomycins. I. Production, isolation and properties of pentenomycins I and II, new antibiotics from Streptomyces eurythermus MCRL 0738.
    Umino K; Furumai T; Matsuzawa N; Awataguchi Y; Ito Y
    J Antibiot (Tokyo); 1973 Sep; 26(9):506-12. PubMed ID: 4792064
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of flow field on the metabolic characteristics of Streptomyces lincolnensis in the industrial fermentation of lincomycin.
    Li X; Zhang J; Tan YL; Li ZH; Yu XF; Xia JY; Chu J; Ge YQ
    J Biosci Bioeng; 2013 Jan; 115(1):27-31. PubMed ID: 22921660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The structure of streptonigrone, and a comment on the biosynthesis of the streptonigrin antibiotics.
    Herlt AJ; Rickards RW; Wu JP
    J Antibiot (Tokyo); 1985 Apr; 38(4):516-8. PubMed ID: 4008345
    [No Abstract]   [Full Text] [Related]  

  • 30. A new pigment from Streptomyces lavendulae.
    Mikami Y; Takahashi K; Fukushima K; Yazawa K; Arai T; Kubo A; Saito N; Kawakami N
    J Antibiot (Tokyo); 1987 Mar; 40(3):385-7. PubMed ID: 3570990
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biosynthetic potential of Str. lincolnensis var. lincolnensis].
    Savage GM
    Antibiotiki; 1967 Jul; 12(7):554-7. PubMed ID: 4876009
    [No Abstract]   [Full Text] [Related]  

  • 32. Biosynthesis of the lincomycins.
    Savage GM
    Postepy Hig Med Dosw; 1972; 26(4):549-62. PubMed ID: 4635071
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic products of microorganisms. 200 Isolation and characterization of niphithricins A, B, and elaiophylin, antibiotics produced by Streptomyces violaceoniger.
    Fiedler HP; Wörner W; Zähner H; Kaiser HP; Keller-Schierlein W; Müller A
    J Antibiot (Tokyo); 1981 Sep; 34(9):1107-18. PubMed ID: 7035426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An enzyme inhibitor, panosialin, produced by Streptomyces. II. Chemistry of panosialin, 5-alkylbenzene-1,3-disulfates.
    Kumagai M; Suhara Y; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1971 Dec; 24(12):870-5. PubMed ID: 5140534
    [No Abstract]   [Full Text] [Related]  

  • 35. Arglecin, a new microbial metabolite isolation and chemical structure.
    Tatsuta K; Tsuchiya T; Someno T; Umezawa S; Umezawa H
    J Antibiot (Tokyo); 1971 Nov; 24(11):735-46. PubMed ID: 5140521
    [No Abstract]   [Full Text] [Related]  

  • 36. Nucleoside antibiotics. Biosynthesis of the maleimide nucleoside antibiotic, showdomycin, by Streptomyces showdoensis.
    Elstner EF; Suhadolnik RJ
    Biochemistry; 1971 Sep; 10(19):3608-14. PubMed ID: 5146574
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation of fluorinated antibiotics followed by 19F NMR spectroscopy. III. Accumulation of 3a-hydroxy-6-fluoroindoline upon addition of 6-fluorotryptophan to the cultured broth of Streptomyces sp. H-63.
    Kawashima A; Seto H; Kato M; Yasuda A; Uchida K; Otake N
    J Antibiot (Tokyo); 1986 Oct; 39(10):1495-7. PubMed ID: 3781917
    [No Abstract]   [Full Text] [Related]  

  • 38. New anthracycline antibiotics: serirubicin and 1-hydroxyserirubicin.
    Uchida T; Imoto M; Masuda T; Yoshimoto H; Imamura K; Sawa T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Jun; 38(6):795-8. PubMed ID: 3860495
    [No Abstract]   [Full Text] [Related]  

  • 39. Duocarmycins, potent antitumor antibiotics produced by Streptomyces sp. structures and chemistry.
    Yasuzawa T; Muroi K; Ichimura M; Takahashi I; Ogawa T; Takahashi K; Sano H; Saitoh Y
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):378-91. PubMed ID: 7774022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new microbial metabolite, sphydrofuran. II. The structure of sphydrofuran.
    Usui T; Umezawa S; Tsuchiya T; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1971 Feb; 24(2):93-106. PubMed ID: 5549387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.